Carregant...
lncRNA CASC2 Enhances (131)I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155
Long noncoding RNA cancer susceptibility candidate 2 (CASC2) has been reported to play an anticancer role in papillary thyroid cancer (PTC). Radioiodine ((131)I) is a common option for the treatment of PTC. However, the role and mechanism of CASC2 in (131)I sensitivity remain unclear. In this study,...
Guardat en:
| Publicat a: | Biomed Res Int |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7591961/ https://ncbi.nlm.nih.gov/pubmed/33134385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7183629 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|